Academic Journal

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

التفاصيل البيبلوغرافية
العنوان: Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
المؤلفون: Meyers, Paul A., Federman, Noah, Daw, Najat, Anderson, Peter. M., Davis, Lara E., Kim, AeRang, Macy, Margaret E., Pietrofeso, Angela, Ratan, Ravin, Riedel, Richard F., Trucco, Matteo, Breitmeyer, James B., Toretsky, Jeffrey A., Ludwig, Joseph A.
المصدر: Journal of Clinical Oncology; 11/1/2024, Vol. 42 Issue 31, p3725-3734, 12p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.24.00020